BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26057517)

  • 41. Classic Kaposi sarcoma mimicking chilblains.
    Vano-Galvan S; Moreno C; Fernández-Lorente M; Jaén P
    Dermatol Online J; 2011 Feb; 17(2):16. PubMed ID: 21382299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases.
    Brambilla L; Romanelli A; Bellinvia M; Ferrucci S; Vinci M; Boneschi V; Miedico A; Tedeschi L
    Br J Dermatol; 2008 Jun; 158(6):1339-44. PubMed ID: 18363766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
    Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT
    J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of classical Kaposi's sarcoma with intralesional injections of cidofovir: report of a case.
    Simonart T; Noel JC; De Dobbeleer G; Parent D; Van Vooren JP; De Clercq E; Snoeck R
    J Med Virol; 1998 Jul; 55(3):215-8. PubMed ID: 9624609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Kaposi's sarcoma].
    Imamura A
    Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy for advanced Kaposi sarcoma.
    Lanzotti VJ; Campos LT; Sinkovics JG; Samuels ML
    Arch Dermatol; 1975 Oct; 111(10):1331-3. PubMed ID: 53034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atypical Kaposi's sarcoma in a patient with vitiligo and pernicious anemia.
    Ruzicka T
    Dermatologica; 1981; 163(2):199-204. PubMed ID: 7286359
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of cutaneous Kaposi's sarcoma with intralesional vincristine.
    Odom RB; Goette DK
    Arch Dermatol; 1978 Nov; 114(11):1693-4. PubMed ID: 718222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatments for classic Kaposi sarcoma: a systematic review of the literature.
    Régnier-Rosencher E; Guillot B; Dupin N
    J Am Acad Dermatol; 2013 Feb; 68(2):313-31. PubMed ID: 22695100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study.
    Nasti G; Errante D; Talamini R; Rizzardini G; Fasan M; Landonio G; Zeroli C; Chichino G; Nigra E; Vaccher E; Tirelli U
    J Clin Oncol; 2000 Apr; 18(7):1550-7. PubMed ID: 10735904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MALT lymphoma and Kaposi sarcoma in an HIV-negative patient.
    Mirabile A; Devizzi L; Gianni AM; Cabras A; Carbone A
    Am J Hematol; 2010 Oct; 85(10):815-7. PubMed ID: 20721890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of weekly paclitaxel for edema and pain in classic Kaposi sarcoma with widespread eruption in the lower legs.
    Omura R; Kamo R; Kusutani N; Fukai K; Ozawa T; Awazawa R; Osawa M; Tsuruta D
    J Dermatol; 2019 May; 46(5):e180-e181. PubMed ID: 30379347
    [No Abstract]   [Full Text] [Related]  

  • 53. Successful treatment of classic Kaposi sarcoma with topical timolol: report of two cases.
    Meseguer-Yebra C; Cardeñoso-Álvarez ME; Bordel-Gómez MT; Fraile-Alonso MC; Pérez-Losada ME; Sánchez-Estella J
    Br J Dermatol; 2015 Sep; 173(3):860-2. PubMed ID: 25704866
    [No Abstract]   [Full Text] [Related]  

  • 54. Kaposi sarcoma secondary to pulmonary tuberculosis: a rare case.
    Guler ZM; Kanbay A; Ciftci B; Kanbay M; Yilmaz A; Agackiran Y; Erdogan Y
    South Med J; 2005 Sep; 98(9):933-4. PubMed ID: 16217989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection.
    Fardet L; Stoebner PE; Bachelez H; Descamps V; Kerob D; Meunier L; Dandurand M; Morel P; Lebbe C
    Cancer; 2006 Apr; 106(8):1785-9. PubMed ID: 16534786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial.
    Curatolo P; Quaglino P; Marenco F; Mancini M; Nardò T; Mortera C; Rotunno R; Calvieri S; Bernengo MG
    Ann Surg Oncol; 2012 Jan; 19(1):192-8. PubMed ID: 21822561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of classical Kaposi's sarcoma with visceral involvement by weekly paclitaxel.
    Engin H; Celik I
    Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):178. PubMed ID: 12069127
    [No Abstract]   [Full Text] [Related]  

  • 58. Low to moderate cumulative doses of pegylated liposomal doxorubicin in the treatment of classic Kaposi sarcoma in elderly patients with comorbidities.
    Potouridou I; Korfitis C; Ioannidou D; Polydorou D; Zakopoulou N; Stratigos AJ; Katsambas AD
    Br J Dermatol; 2008 Feb; 158(2):431-2. PubMed ID: 18067475
    [No Abstract]   [Full Text] [Related]  

  • 59. Persistently recurring Mediterranean Kaposi's sarcoma on skin grafts.
    Brambilla L; Boneschi V; Zampieri M; Bruognolo L; Fossati S
    Int J Dermatol; 1996 May; 35(5):362-4. PubMed ID: 8734662
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy of Vinblastine in Primary Cutaneous Anaplastic Large Cell Lymphoma.
    Laly P; Ingen-Housz-Oro S; Beylot-Barry M; Verneuil L; Adamski H; Brice P; Bagot M
    JAMA Dermatol; 2015 Sep; 151(9):1030-1. PubMed ID: 26108120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.